BioWorld - Thursday, February 5, 2026

nasdaq

56 items

renal cell carcinoma

56 items

medshine discovery inc.

56 items

telix pharmaceuticals ltd.

56 items

cgm

56 items

gtpase kras inhibitors

56 items

prognosis

56 items

leqembi

55 items

3clpro inhibitors

55 items

shanghai institute of materia medica

55 items

supply chain

55 items

btk inhibitors

55 items

coronary artery disease

55 items

ionis pharmaceuticals inc.

55 items

chronic pain

55 items

taiwan

54 items

investment

54 items

roche ag

54 items

parp-1 inhibitors

53 items

monthly biopharma financings analysis

53 items